# Bal Pharma (NSE: BALPHARMA) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/BALPHARMA · Pivot · prices to 30 Sep 2026

Bal Pharma (NSE: BALPHARMA) closed at ₹109.58 on 30 Sep 2026. With a market capitalisation of ₹174 Cr, it ranks 2351st by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Drug Manufacturers - Specialty & Generic.

At its last close the stock traded at 27.7× trailing earnings, against a return on equity of 7.7% in FY26. Over the past year the share price has risen 28.9%. Its 52-week range is ₹60.00 (30 Mar 2026) to ₹124.60 (10 Sep 2026); the last close is 12.1% below the high. Promoters held 50.86% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹109.58 |
| Market cap | ₹174 Cr |
| P/E (trailing) | 27.7 |
| ROE | 7.7% (FY26) |
| ROCE | 18.0% (FY26) |
| Debt to equity | 1.94 |
| 52-week high | ₹124.60 (10 Sep 2026) |
| 52-week low | ₹60.00 (30 Mar 2026) |
| 1-year return | +28.9% |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹303 Cr | ₹7 Cr |
| FY24 | ₹339 Cr | ₹7 Cr |
| FY23 | ₹304 Cr | ₹3 Cr |
| FY22 | ₹281 Cr | ₹6 Cr |
| FY21 | ₹251 Cr | ₹5 Cr |
| FY20 | ₹171 Cr | −₹13 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 50.86%
- Foreign institutions: 0.15%
- Non-institutions: 48.99%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Accretion Nutra](https://app.pivotnow.in/stock/ANL) | — | ₹184 Cr | — | — |
| [Earkart](https://app.pivotnow.in/stock/EARKART) | — | ₹182 Cr | — | — |
| [Novelix Pharma](https://app.pivotnow.in/stock/NOVELIX) | — | ₹181 Cr | — | — |
| [Medico Remedies](https://app.pivotnow.in/stock/MEDICO) | ₹20.71 | ₹172 Cr | 13.1 | — |
| [Vaidya Sane Ayu](https://app.pivotnow.in/stock/MADHAVBAUG) | ₹161.10 | ₹169 Cr | — | — |
| [Take Solutions](https://app.pivotnow.in/stock/TAKE) | ₹11.23 | ₹166 Cr | 38.7 | — |

## Questions and answers

### What is the share price of Bal Pharma today?

Bal Pharma (NSE: BALPHARMA) last closed at ₹109.58 on 30 Sep 2026. Its 52-week high is ₹124.60 and its 52-week low is ₹60.00.

### What is the market cap of Bal Pharma?

Bal Pharma's market capitalisation is ₹174 Cr (₹174 Cr) at the 22 Oct 2026 close, ranking 2351st among the NSE companies Pivot tracks.

### What is the P/E ratio of Bal Pharma?

Bal Pharma trades at a trailing P/E of 27.7.

### What is the ROE and ROCE of Bal Pharma?

Return on equity was 7.7% in FY26 and return on capital employed was 18.0% in FY26 (consolidated figures).

### Is Bal Pharma a debt-free company?

No. Bal Pharma's debt-to-equity ratio was 1.94 in FY26, with total debt of ₹32 Cr.

### How has Bal Pharma stock performed over the last year?

Bal Pharma's share price has risen 28.9% over the past year, +37.8% over three months and +28.9% over one month, to the 22 Oct 2026 close.

### What is the shareholding pattern of Bal Pharma?

As of 30 Jun 2026: promoters 50.86%, foreign institutions 0.15%, non-institutions 48.99%.

### Who are Bal Pharma's competitors?

The listed Pharma & Healthcare companies closest to Bal Pharma by market cap are Accretion Nutra, Earkart, Novelix Pharma, Medico Remedies, Vaidya Sane Ayu and Take Solutions.

### Is Bal Pharma a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Bal Pharma's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on BALPHARMA against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.